Recursion Pharmaceuticals (RXRX) shares closed up 27% after the Food and Drug Administration (FDA) said it wants to phase out ...

Recursion Pharmaceuticals, a trailblazing TechBio company, has made a significant stride in the realm of oncology by dosing the first patient in its Phase 1 clinical trial for a potential B-cell ...

在科技飞速进步的今天，人工智能（AI）正在悄然改变各个领域，尤其是在医药研发方面。最近，Recursion Pharmaceuticals（RXRX.US）等AI医药开发概念股的股价大幅上涨，吸引了投资者的目光。根据智通财经APP的报道，Recursion Pharmaceuticals的股价上涨近23%，而Certara（CERT.US）和Simulations Plus（SLP.US）也分别上 ...

H.C. Wainwright lowered the firm’s price target on Citius Pharmaceuticals (CTXR) to $4 from $100 and keeps a Buy rating on the shares following ...

Conduit Pharmaceuticals (CDT) announces the filing of two groundbreaking patents for tapinarof, VTAMA, including a dual active cocrystal, ...

An Australian woman has given birth to a stranger's baby after a fertility doctor accidentally implanted the wrong embryo, the clinic owner said in its apology letter while blaming the mix-up on ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

Trump may have hit the brakes on reciprocal tariffs levied against many of the US’ top trading partners, but the duties ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.